IL6 and cancer: This shock also leads to the activation of inflammation dominated by IL-6 and associated inflammatory network to reprogram both cancer cells and the stroma cells and creates microenvironment to promote the growth of newly reprogrammed daughter cells for the resistance and disease relapse.